Table 1 Comparison of ARB colonization rates according to the patient’s territory of residence (2015–2017) using Reunion Island (France) as reference
Patients (n) | ARB positive patients | ESBL-E | MRSA | CRE | |||||
|---|---|---|---|---|---|---|---|---|---|
OR (95% CI) | Prevalence (95% CI) | OR (95% CI) | Prevalence (95% CI) | OR (95% CI) | Prevalence (95% CI) | OR (95% CI) | Prevalence (95% CI) | ||
Seychelles | 13 | 7.0 [2.3–23.2] ** | 61.5% [35.5–82.3%] | 7.4 [2.4–24.5] ** | 61.5% [35.5–82.3%] | 32.9 [4.8–140.8] ** | 15.4% [4.3–42.2%] | _ | _ |
Madagascar | 322 | 3.1 [2.4–3.9] ** | 41.3% [36.1–46.8%] | 3.1 [2.4–3.9] ** | 40.1% [34.9–45.5%] | 2.3 [0.7–6.6] | 1.2% [0.5–3.2%] | 2.7 [0.8–8.2] | 1.2% [0.5–3.2%] |
Comoros | 30 | 2.2 [1.0–4.6] * | 33.3% [19.2–51.2%] | 2.3 [1.0–4.8] * | 33.3% [19.2–51.2%] | _ | _ | _ | _ |
Mayotte | 1475 | 1.6 [1.3–1.8] ** | 26.4% [24.3–28.8%] | 1.5 [1.3–1.8] ** | 24.7% [22.5–26.9%] | 3.6 [1.9–7.4] ** | 2.0% [1.4–2.8%] | 2.1 [0.9–4.8] | 0.9% [0.6–1.6%] |
Mauritius | 111 | 1.5 [1.0–2.4] | 26.1% [18.9–35.0%] | 1.1 [0.7–1.8] | 19.8% [13.5–28.2%] | _ | _ | 19.2 [7.5–48.6] ** | 8.1% [4.3–14.7%] |
Reunion | 2184 | 1 (ref) | 18.7% [17.1–20.4%] | 1 (ref) | 17.9% [16.3–19.5%] | 1 (ref) | 0.5% [0.3–1.0%] | 1 (ref) | 0.5% [0.2–0.8%] |